abstract |
The present invention relates to novel methods of cholesterol regulation by inhibiting the proprotein convertase subtilisin/kexin type 9 (PCSK9) with fatty acid derivatives; and novel methods for the treatment or prevention of metabolic diseases comprising administering an effective amount of fatty acid derivatives. The invention also relates to biologically active derivatives of fatty acids and their use in the treatment of metabolic diseases. |